The EU Commission clears a merger subject to remedies in the animal health market (Boehringer Ingelheim / Sanofi)

MERGERS: COMMISSION APPROVES ACQUISITION OF SANOFI'S ANIMAL HEALTH BUSINESS MERIAL BY BOEHRINGER INGELHEIM, SUBJECT TO CONDITIONS* The European Commission has approved under the EU Merger Regulation the acquisition of the animal health business of Sanofi (Merial) of France by Boehringer Ingelheim (BI) of Germany. The decision is conditional on the divestment of a number of animal health vaccines and pharmaceuticals. The proposed transaction leads to a combination of two key competitors in the development, manufacturing, marketing and sale of animal health products across the European Economic Area (EEA). The Commission's investigation focused on overlaps between BI and Merial's activities in the following areas: Biologicals: swine and

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

European Commission, The EU Commission clears a merger subject to remedies in the animal health market (Boehringer Ingelheim / Sanofi), 9 November 2016, e-Competitions Merger Remedies, Art. N° 82313

Visites 282

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues